Cargando…

Sustained benefit from combined plasmapheresis and allogeneic mesenchymal stem cells transplantation therapy in systemic sclerosis

BACKGROUND: Systemic sclerosis (SSc) is an autoimmune disease involving the skin and several internal organs. Most therapies available for this disease are symptomatic. Given the difficulty in treating SSc, we conducted this study to investigate the effect of combined plasmapheresis (PE) and allogen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huayong, Liang, Jun, Tang, Xiaojun, Wang, Dandan, Feng, Xuebing, Wang, Fan, Hua, Bingzhu, Wang, Hong, Sun, Lingyun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518166/ https://www.ncbi.nlm.nih.gov/pubmed/28724445 http://dx.doi.org/10.1186/s13075-017-1373-2

Ejemplares similares

A Long-Term Follow-Up Study of Allogeneic Mesenchymal Stem/Stromal Cell Transplantation in Patients with Drug-Resistant Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2018)

Double Allogenic Mesenchymal Stem Cells Transplantations Could Not Enhance Therapeutic Effect Compared with Single Transplantation in Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2012)

Safety analysis in patients with autoimmune disease receiving allogeneic mesenchymal stem cells infusion: a long-term retrospective study
por: Liang, Jun, et al.
Publicado: (2018)

Transplantation of mesenchymal stem cells in a laryngeal carcinoma patient with radiation myelitis
por: Liang, Jun, et al.
Publicado: (2015)

Allogenic Umbilical Cord-Derived Mesenchymal Stromal Cells Sustain Long-Term Therapeutic Efficacy Compared With Low-Dose Interleukin-2 in Systemic Lupus Erythematosus
por: Cao, Zhouli, et al.
Publicado: (2023)

Umbilical Cord-Derived Mesenchymal Stem Cells Inhibit Cadherin-11 Expression by Fibroblast-Like Synoviocytes in Rheumatoid Arthritis
por: Zhao, Cheng, et al.
Publicado: (2015)

Olf1/EBF associated zinc finger protein interfered with antinuclear antibody production in patients with systemic lupus erythematosus
por: Feng, Xuebing, et al.
Publicado: (2010)

Serum IFN‐γ Predicts the Therapeutic Effect of Mesenchymal Stem Cells Transplantation in Systemic Lupus Erythematosus Patients
por: Wang, Dandan, et al.
Publicado: (2017)

Mesenchymal Stem Cells Promote the Osteogenesis in Collagen-Induced Arthritic Mice through the Inhibition of TNF-α
por: Liu, Chang, et al.
Publicado: (2018)

Association Between Mycophenolate Mofetil Use and Subsequent Infections Among Hospitalized Patients with Systemic Lupus Erythematosus: A Nested Case–Control Study
por: Guo, Qingqing, et al.
Publicado: (2023)

Prognostic Factors for Clinical Response in Systemic Lupus Erythematosus Patients Treated by Allogeneic Mesenchymal Stem Cells
por: Wen, Lihui, et al.
Publicado: (2019)

Allogeneic mesenchymal stem cells inhibited T follicular helper cell generation in rheumatoid arthritis
por: Liu, Rui, et al.
Publicado: (2015)

Inhibition of Aberrant Circulating Tfh Cell Proportions by Corticosteroids in Patients with Systemic Lupus Erythematosus
por: Feng, Xuebing, et al.
Publicado: (2012)

Reduced Let-7f in Bone Marrow-Derived Mesenchymal Stem Cells Triggers Treg/Th17 Imbalance in Patients With Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2020)

A CD8 T Cell/Indoleamine 2,3-Dioxygenase Axis Is Required for Mesenchymal Stem Cell Suppression of Human Systemic Lupus Erythematosus
por: Wang, Dandan, et al.
Publicado: (2014)

Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantation
por: Vogl, Ursula, et al.
Publicado: (2016)

Mesenchymal Stem Cells in Systemic Sclerosis: Allogenic or Autologous Approaches for Therapeutic Use?
por: Rozier, Pauline, et al.
Publicado: (2018)

Umbilical Cord-Derived Mesenchymal Stem Cells Suppress Autophagy of T Cells in Patients with Systemic Lupus Erythematosus via Transfer of Mitochondria
por: Chen, Jinyun, et al.
Publicado: (2016)

Mesenchymal Stem Cells from Patients with Rheumatoid Arthritis Display Impaired Function in Inhibiting Th17 Cells
por: Sun, Yue, et al.
Publicado: (2015)

Mesenchymal stem cell transplantation ameliorates Sjögren’s syndrome via suppressing IL-12 production by dendritic cells
por: Shi, Bingyu, et al.
Publicado: (2018)

Mesenchymal Stem Cells May Ameliorate Nephrotic Syndrome Post-Allogeneic Hematopoietic Stem Cell Transplantation-Case Report
por: Zhang, Xin, et al.
Publicado: (2017)

Association of TNF-α with Impaired Migration Capacity of Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
por: Geng, Linyu, et al.
Publicado: (2014)

Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice
por: Li, Chenghai, et al.
Publicado: (2021)

Allogeneic Stem Cell Transplantation Combined With Transfusion of Mesenchymal Stem Cells in Primary Myelofibrosis: A Multicenter Retrospective Study
por: Wang, Qingyuan, et al.
Publicado: (2022)

Tackling mantle cell lymphoma (MCL): Potential benefit of allogeneic stem cell transplantation
por: Shanbhag, Satish, et al.
Publicado: (2010)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Combined meta-analysis of systemic effects of allogeneic stem cell transplantation and systemic sclerosis
por: Grigoryev, Dmitry N, et al.
Publicado: (2014)

Mesenchymal stem cell transplantation alleviates experimental Sjögren's syndrome through IFN-β/IL-27 signaling axis
por: Yao, Genhong, et al.
Publicado: (2019)

Immunogenicity of allogeneic mesenchymal stem cells
por: Schu, Sabine, et al.
Publicado: (2012)

Characteristics of Hearing Loss in Patients with Systemic Lupus Erythematosus
por: Chen, Huixian, et al.
Publicado: (2022)

Intravenous transplantation of allogeneic bone marrow mesenchymal stem cells and its directional migration to the necrotic femoral head
por: Li, Zhang-hua, et al.
Publicado: (2011)

Mesenchymal stem cell transplantation alleviated atherosclerosis in systemic lupus erythematosus through reducing MDSCs
por: Yao, Genhong, et al.
Publicado: (2022)

The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation
por: Dybko, Jarosław, et al.
Publicado: (2023)

Development of Clinical Decision Models for the Prediction of Systemic Lupus Erythematosus and Sjogren’s Syndrome Overlap
por: Han, Yan, et al.
Publicado: (2023)

Safety and tracking of intrathecal allogeneic mesenchymal stem cell transplantation in healthy and diseased horses
por: Barberini, Danielle Jaqueta, et al.
Publicado: (2018)

Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs
por: Benavides, Felipe Pérez, et al.
Publicado: (2021)

Sustained immunotolerance in multiple sclerosis after stem cell transplant
por: Visweswaran, Malini, et al.
Publicado: (2022)

Pathophysiological changes of inflammatory syndrome in multiple sclerosis after instituting therapeutic plasmapheresis
por: Vlaic, S, et al.
Publicado: (2017)

Plasmapheresis for systemic vasculitis
por: Fukuoka, Kazuhito, et al.
Publicado: (2022)

In Vivo Immunogenic Response to Allogeneic Mesenchymal Stem Cells and the Role of Preactivated Mesenchymal Stem Cells Cotransplanted with Allogeneic Islets
por: Oliveira, Régis Linhares, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_80adf75j1qcavgvd06pi44m3o5